Nauck Nauck MA MA Update on developments with SGLT2 inhibitors in the management of type 2 diabetes Update on developments with SGLT2 inhibitors in the management of type 2 diabetes Drug Des Devel Ther Drug Des Devel Ther 2014 2014 8 8 1335 1335 1380 1380 10.2147/DDDT.S50773 10.2147/DDDT.S50773. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.